FLG and Alzheimer disease: Filaggrin expression was reduced slightly in the presence of Th2 cytokines, suggesting that this effect is not one of the earliest and constant features occurring during the initial phases of AD lesion formation, but it can represent a later pathogenic event in AD as a clear impairment of its expression is clinically reported in bioptic samples [49].